ArticleFrontiers in cellular and infection microbiology2026
Efficacy and short-term safety of intravenous omadacycline as second-line therapy for macrolide- unresponsive Mycoplasma pneumoniae pneumonia in children: a retrospective cohort study.
Yang Yu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.